Deucravacitinib Yields Higher Minimal Disease Activity Response Than Placebo in PsANovember 22, 2024Psoriatic Arthritis
Apremilast Reduces MRI-Detected Inflammation in Joints and Entheses in PsANovember 22, 2024Psoriatic Arthritis
Guselkumab Improves Disease Activity Across Multiple Domains in TNFi-IR PsANovember 22, 2024Psoriatic Arthritis
Rheumatology NewsUpdated Guidance for Psoriatic Arthritis Ultrasound Comes at Time of Growing Use, New TechnologyNovember 18, 2024Psoriatic ArthritisACR 2024
Commentary: Factors Affecting PsA and Updated Therapy Efficacy Data, November 2024October 29, 2024Psoriatic Arthritis
Rheumatology NewsTherapeutic Drug Monitoring in Rheumatology: A Promising Outlook But Many Barriers to OvercomeOctober 23, 2024Rheumatoid ArthritisSpondyloarthropathiesPediatricsPsoriatic ArthritisLupus & Connective Tissue DiseasesAnkylosing spondylitis
